Literature DB >> 1935818

Human growth hormone replacement therapy: pharmacological and clinical aspects.

J O Jørgensen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1935818     DOI： 10.1210/edrv-12-3-189

Source DB:  PubMed          Journal:  Endocr Rev        ISSN： 0163-769X            Impact factor:   19.871


× No keyword cloud information.
  6 in total

1.  Preparation and characterization of poly(D,L-lactide-co-glycolide) microspheres for controlled release of human growth hormone.

Authors:  Yilmaz Capan; Ge Jiang; Stefano Giovagnoli; Kyu-Heum Na; Patrick P DeLuca
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

2.  Differential in vivo activities of bovine growth hormone analogues.

Authors:  J Kopchick; X Z Chen; Y Li; R W Steger; J S Yun; T E Wagner; A Bartke
Journal:  Transgenic Res       Date:  1998-01       Impact factor: 2.788

Review 3.  Growth hormone cotreatment with gonadotropins in ovulation induction.

Authors:  P G Artini; A A de Micheroux; G D'Ambrogio
Journal:  J Endocrinol Invest       Date:  1996-12       Impact factor: 4.256

4.  Preclinical and clinical in vitro in vivo correlation of an hGH dextran microsphere formulation.

Authors:  K D F Vlugt-Wensink; R de Vrueh; M G Gresnigt; C M Hoogerbrugge; S C van Buul-Offers; L G J de Leede; L G W Sterkman; D J A Crommelin; W E Hennink; R Verrijk
Journal:  Pharm Res       Date:  2007-10-11       Impact factor: 4.200

Review 5.  Growth Hormone and IGF1 Actions in Kidney Development and Function.

Authors:  Evgenia Gurevich; Yael Segev; Daniel Landau
Journal:  Cells       Date:  2021-11-30       Impact factor: 6.600

6.  Renal effects of growth hormone in health and in kidney disease.

Authors:  Dieter Haffner; Andrea Grund; Maren Leifheit-Nestler
Journal:  Pediatr Nephrol       Date:  2021-06-18       Impact factor: 3.714
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.